<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01687062</url>
  </required_header>
  <id_info>
    <org_study_id>EK2012N31</org_study_id>
    <nct_id>NCT01687062</nct_id>
  </id_info>
  <brief_title>Iron Absorption From Tef-injera in Women of Reproductive Age</brief_title>
  <official_title>Iron Absorption From Tef-injera in Women of Reproductive Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Swiss Federal Institute of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anemia is one of the most common health problems all over the world with around half of
      preschool-aged children (&lt;5 years) and one third of women affected. Nutritional iron
      deficiency is a major reason for anemia in infants, young children and women of reproductive
      age who have especially high iron requirements that are difficult to meet in regions where
      the major diet is based on plant foods. So in Ethiopia, where injera is the major staple
      food. Despite high levels of iron in tef, the most favored cereal for injera, the iron
      bioavailability is assumed to be very low due to the high levels of phytic acid found in tef.

      The aim of this study is to determine the iron bioavailability in women from injera prepared
      in a traditional way and investigate the potential of methods to improve the bioavaiability.
      Therefore, a 50/50 and a 25/75 blend of FeSO4 and NaFeEDTA for iron fortification will be
      evaluated. Further the potential positive impact of phytic acid reduction on the iron
      bioavailability will be investigated. The phytic acid reduction will be achieved in two
      different ways, by addition of whole grain wheat as source of phytase and addition of a
      commercially available microbial phytase. The studies will be conducted in healthy women
      using stable isotope techniques.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Iron absorption</measure>
    <time_frame>17 days</time_frame>
    <description>Test meals with isotopic iron labels will be administrated on day 1-3. Whole blood samples will be collected on day 17 (14 after the last test meal) to analyze the iron isotope ratios.</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Iron Deficiency</condition>
  <arm_group>
    <arm_group_label>FeSO4 + high phytate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>injera test meal 1 labeled with a 4 mg staple iron isotope tag</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FeSO4 + medium phytate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injera test meal 2 labeled with a 4 mg staple iron isotope tag</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FeSO4 + low phytate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injera test meal 3 labeled with a 4 mg staple iron isotope tag</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FeSO4 + NaFeEDTA (1:1) + high phytate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injera test meal 4 labeled with a 4 mg staple iron isotope tag</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FeSO4 + NaFeEDTA (1:3) + high phytate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injera test meal 5 labeled with a 4 mg staple iron isotope tag</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FeSO4</intervention_name>
    <arm_group_label>FeSO4 + high phytate</arm_group_label>
    <arm_group_label>FeSO4 + medium phytate</arm_group_label>
    <arm_group_label>FeSO4 + low phytate</arm_group_label>
    <arm_group_label>FeSO4 + NaFeEDTA (1:1) + high phytate</arm_group_label>
    <arm_group_label>FeSO4 + NaFeEDTA (1:3) + high phytate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>reduction of phytate</intervention_name>
    <arm_group_label>FeSO4 + medium phytate</arm_group_label>
    <arm_group_label>FeSO4 + low phytate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NaFeEDTA</intervention_name>
    <arm_group_label>FeSO4 + NaFeEDTA (1:1) + high phytate</arm_group_label>
    <arm_group_label>FeSO4 + NaFeEDTA (1:3) + high phytate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Reproductive age females 18-40 years

          -  Maximum body weight 65 kg

          -  Normal body mass index (18.5-25 kg/m2)

          -  No intake of mineral/vitamin supplements 2 weeks before and during the study

          -  No metabolic or gastrointestinal disorders or chronic diseases

          -  Not pregnant or lactating

          -  No regular intake of medication (except oral contraceptives)

          -  No blood donation or significant blood loss (accident, surgery) over the past 4 months

          -  Not currently participating in another clinical trial or having participated in
             another clinical trial during the last 3 months prior to the beginning of this study

          -  No former participation in a study involving administration of iron stable isotopes

          -  No eating disorders or food allergy

          -  Subject who can be expected and are willing to comply with study protocol

          -  Having received oral and written information about the aims and procedures of the
             study

          -  Having provided oral and written informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ETH Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8092</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2012</study_first_submitted>
  <study_first_submitted_qc>September 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2012</study_first_posted>
  <last_update_submitted>October 11, 2013</last_update_submitted>
  <last_update_submitted_qc>October 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Swiss Federal Institute of Technology</investigator_affiliation>
    <investigator_full_name>Prof. Michael B. Zimmermann</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>NaFeEDTA</keyword>
  <keyword>phytate</keyword>
  <keyword>injera</keyword>
  <keyword>iron absorption</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Fe(III)-EDTA</mesh_term>
    <mesh_term>Edetic Acid</mesh_term>
    <mesh_term>Ferric Compounds</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

